Product
Runcaciguat
Aliases
Runcaciguat (BAY1101042)
1 clinical trial
1 indication
Indication
Diabetic RetinopathyClinical trial
A Phase 2 Randomized, Placebo-controlled, Double-masked Proof-of-concept Study to Investigate the Efficacy and Safety of Runcaciguat (BAY 1101042) in Patients With Moderately Severe to Severe Non-proliferative Diabetic RetinopathyStatus: Active (not recruiting), Estimated PCD: 2024-04-25